David Blum

David Blum publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where David Blum sits on this spectrum.

David Blum D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where David Blum sits on this spectrum.

Overview

Best Publications

• Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

  David Blum;Sakina Torch;Nathalie Lambeng;Marie-France Nissou

  1615
  Citations

• NLRP3 inflammasome activation drives tau pathology

  Christina Ising;Carmen Venegas;Shuangshuang Zhang;Hannah Scheiblich

  1432
  Citations

• 3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

  Emmanuel Brouillet;Carine Jacquard;Nicolas Bizat;David Blum

  411
  Citations

• Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

  Nicolas Sergeant;Alexis Bretteville;Malika Hamdane;Marie-Laure Caillet-Boudin

  350
  Citations

• Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?

  Cyril Laurent;Luc Buée;David Blum;David Blum

  344
  Citations

• Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology.

  Annerieke Sierksma;Ashley Lu;Renzo Mancuso;Nicola Fattorelli

  291
  Citations

• Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment.

  Le Freche H;Brouillette J;Fernandez-Gomez Fj;Patin P

  281
  Citations

• Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy

  Cyril Laurent;Guillaume Dorothée;Guillaume Dorothée;Stéphane Hunot;Elodie Martin

  275
  Citations

• Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach

  Laetitia Troquier;Raphaelle Caillierez;Sylvie Burnouf;Francisco J Fernandez-Gomez

  233
  Citations

• Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.

  Cyril Laurent;Cyril Laurent;Sabiha Eddarkaoui;Sabiha Eddarkaoui;Maxime Derisbourg;Maxime Derisbourg;Antoine Leboucher;Antoine Leboucher

  227
  Citations

• Atypical, non-standard functions of the microtubule associated Tau protein

  Ioannis Sotiropoulos;Marie-Christine Galas;Joana M. Silva;Efthimios Skoulakis

  218
  Citations

• Tau deletion promotes brain insulin resistance.

  Elodie Marciniak;Antoine Leboucher;Emilie Caron;Tariq Ahmed;Tariq Ahmed

  215
  Citations

• Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.

  Karim Belarbi;Sylvie Burnouf;Francisco-Jose Fernandez-Gomez;Cyril Laurent

  215
  Citations

• Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid-β1–42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model

  Jonathan Brouillette;Raphaëlle Caillierez;Nadège Zommer;Claire Alves-Pires

  210
  Citations

• Clinical potential of minocycline for neurodegenerative disorders.

  David Blum;Abdelwahed Chtarto;Liliane Tenenbaum;Jacques Brotchi

  199
  Citations

• IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer’s disease

  Helena C. Brigas;Miguel Ribeiro;Joana E. Coelho;Rui Gomes;Rui Gomes

  194
  Citations

• A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

  C Laurent;C Laurent;S Burnouf;S Burnouf;B Ferry;V L Batalha

  189
  Citations

• Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.

  Pauline Vercruysse;Didier Vieau;David Blum;Åsa Petersén

  185
  Citations

• Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors

  Mariana Temido-Ferreira;Diana G. Ferreira;Vânia L. Batalha;Inês Marques-Morgado

  177
  Citations

• The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.

  Elodie Marciniak;Elodie Marciniak;Emilie Faivre;Emilie Faivre;Patrick Dutar;Claire Alves Pires;Claire Alves Pires

  175
  Citations

• Extracellular toxicity of 6-hydroxydopamine on PC12 cells.

  David Blum;Sakina Torch;Marie-France Nissou;Alim-Louis Benabid

  173
  Citations

• Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics

  David Blum;Raphaël Hourez;Marie-Christine Galas;Patrizia Popoli

  166
  Citations